Medical research scientists are working around Australia and the globe to better understand neurological conditions and their causes, seeking new or better treatments and ultimately, cures. Here are details of current research projects and exciting discoveries in the field of neurological research.
MSWA recommends that you discuss any research results, or new treatments mentioned, with your neurologist; as they know your individual circumstances and can provide personalised advice.
Researchers at the QIMR Berghofer Medical Research Institute, are undertaking ground-breaking research to help identify genetic factors influencing risk of developing Parkinson’s disease. This research, named the Australian Parkinson’s Genetics Study (APGS), will contribute towards the largest study of Parkinson’s genetics ever undertaken, the Global Parkinson’s Genetics Program (GP2).
A recent study shows that women who’ve experienced infertility, miscarriage, and stillbirth are at a higher risk for both non-fatal and fatal stroke later in life. While infertility and pregnancy loss may not be preventable, genetic factors or endocrine disruptions may help explain the association with increased stroke risk, according to the research.
MS predominately affects working age adults and has effects on many facets of life including family, work and social interactions. People with MS face significant employment-related challenges and understanding and preparing for these may improve later employment outcomes.
MND clinical trial of cancer drug, monepantel (MPL), is set to begin later this month. The tablets are designed in a particular shape and size to help MND patients swallow them and reach specific blood drug levels targeted for this disease.
Current evidence is insufficient for routine clinical use of yoga therapy for migraine. Several studies have explored the efficacy of yoga therapy for migraine patients, but the results are conflicting.
The first participant has been enrolled in a new clinical trial that is testing whether an antihistamine in combination with a diabetes medication might promote the repair of the myelin sheath in people with multiple sclerosis (MS).
MSWA collaborated with MSA and MS societies around Australia to put together this important research on the access and impact MS nurse care has on health outcomes of patient.
A new drug delays motor neurone disease progression and improves cognitive and clinical symptoms according to recently announced trial results.
Recent data has shown that regular exercise may ameliorate motor symptoms in Parkinson’s disease (PD). This study aims to investigate how intended exercise impacts motor and non-movement symptoms of PD.
Investigating the potential disease-modifying and neuroprotective efficacy of exercise therapy early in the disease course of multiple sclerosis. This study investigated the effect of early exercise on relapse rate, global brain atrophy and secondary magnetic resonance imaging (MRI) outcomes.
If you would like more information about specific research, email us at customerservice@mswa.org.au.
Click here to read the latest edition of Vitality – MSWA's monthly e-newsletter covering the latest articles relating to research, medical advancements and general wellbeing for people living with MS and other neurological conditions.